Population-based cohort study: proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events

BACKGROUND: Approximately half of all women suffer from heartburn at some stage during pregnancy. The most effective treatment is proton pump inhibitors, but the safety of use during pregnancy cannot be guaranteed. This study aimed to elucidate the effect of proton pump inhibitors on the risk of pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Breddels, Esmee M., Simin, Johanna, Fornes, Romina, Lilja Engstrand, Helene, Engstrand, Lars, Bruyndonckx, Robin, Brusselaers, Nele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768950/
https://www.ncbi.nlm.nih.gov/pubmed/36539798
http://dx.doi.org/10.1186/s12916-022-02673-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768950/
https://www.ncbi.nlm.nih.gov/pubmed/36539798
http://dx.doi.org/10.1186/s12916-022-02673-x

Ejemplares similares